insights_auto
Why is NWBO down 3,27%?
Dive Deeperchevron_right
NWBO:OTCMKTS
Northwest Biotherapeutics Inc
0,15 $
arrow_downward
-3,27%(-0,0052) 1D
15 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NWBO...
Open
0,16 $
High
0,17 $
Low
0,15 $
Mkt. cap
268,07 մլն
Avg. vol.
4,00 մլն
Volume
4,43 մլն
52-wk high
0,34 $
52-wk low
0,14 $
EPS
-0,03 $
Beta
-0,62
Shares outstanding
1,71 մլրդ
No. of employees
105
Open
0,16 $
High
0,17 $
Low
0,15 $
Mkt. cap
268,07 մլն
Avg. vol.
4,00 մլն
Volume
4,43 մլն
52-wk high
0,34 $
52-wk low
0,14 $
EPS
-0,03 $
Beta
-0,62
Shares outstanding
1,71 մլրդ
No. of employees
105
News stories
From web sources and news partners
Business Wire
·
51 րոպե առաջ
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TradingView
·
43 րոպե առաջ
Iambic Therapeutics, AI-Driven Drug Discovery and Development, Files for Nasdaq Global Select Market IPO
CNBC
·
3 ժամ առաջ
Equal-weight failed. Now tech stocks look shaky again. So what should you do about S&P 500 risk?
Investing.com
·
34 րոպե առաջ
Frazier Life Sciences SPAC raises $75M in Nasdaq IPO
Profile
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
About Northwest Biotherapeutics Inc